Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A4HG72
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.325 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.588 |
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.398 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.519 |
CLV_PCSK_FUR_1 | 84 | 88 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.325 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.580 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.381 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.532 |
CLV_PCSK_PC1ET2_1 | 330 | 332 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.609 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.249 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.282 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.493 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.642 |
DOC_CKS1_1 | 149 | 154 | PF01111 | 0.450 |
DOC_MAPK_gen_1 | 278 | 285 | PF00069 | 0.520 |
DOC_MAPK_gen_1 | 328 | 335 | PF00069 | 0.528 |
DOC_MAPK_MEF2A_6 | 172 | 179 | PF00069 | 0.362 |
DOC_MAPK_MEF2A_6 | 254 | 262 | PF00069 | 0.355 |
DOC_PP2B_LxvP_1 | 177 | 180 | PF13499 | 0.447 |
DOC_PP2B_LxvP_1 | 283 | 286 | PF13499 | 0.355 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.604 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.681 |
DOC_USP7_UBL2_3 | 324 | 328 | PF12436 | 0.456 |
DOC_USP7_UBL2_3 | 340 | 344 | PF12436 | 0.693 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.450 |
DOC_WW_Pin1_4 | 229 | 234 | PF00397 | 0.390 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.760 |
LIG_14-3-3_CanoR_1 | 200 | 208 | PF00244 | 0.449 |
LIG_BRCT_BRCA1_1 | 222 | 226 | PF00533 | 0.378 |
LIG_deltaCOP1_diTrp_1 | 111 | 117 | PF00928 | 0.683 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.405 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.638 |
LIG_FHA_2 | 97 | 103 | PF00498 | 0.718 |
LIG_LIR_Gen_1 | 296 | 307 | PF02991 | 0.588 |
LIG_LIR_Nem_3 | 296 | 302 | PF02991 | 0.596 |
LIG_LYPXL_S_1 | 119 | 123 | PF13949 | 0.480 |
LIG_LYPXL_yS_3 | 120 | 123 | PF13949 | 0.480 |
LIG_SH2_NCK_1 | 299 | 303 | PF00017 | 0.479 |
LIG_SH2_SRC | 193 | 196 | PF00017 | 0.509 |
LIG_SH2_SRC | 299 | 302 | PF00017 | 0.484 |
LIG_SH2_STAP1 | 187 | 191 | PF00017 | 0.480 |
LIG_SH2_STAP1 | 234 | 238 | PF00017 | 0.356 |
LIG_SH2_STAP1 | 52 | 56 | PF00017 | 0.617 |
LIG_SH2_STAT3 | 29 | 32 | PF00017 | 0.609 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 193 | 196 | PF00017 | 0.597 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.697 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.633 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.442 |
LIG_SH3_3 | 170 | 176 | PF00018 | 0.362 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.440 |
LIG_SUMO_SIM_anti_2 | 38 | 49 | PF11976 | 0.676 |
LIG_SUMO_SIM_par_1 | 187 | 192 | PF11976 | 0.430 |
LIG_TYR_ITIM | 118 | 123 | PF00017 | 0.440 |
LIG_TYR_ITIM | 126 | 131 | PF00017 | 0.456 |
LIG_UBA3_1 | 132 | 138 | PF00899 | 0.310 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.355 |
MOD_CK1_1 | 232 | 238 | PF00069 | 0.360 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.657 |
MOD_CK2_1 | 96 | 102 | PF00069 | 0.686 |
MOD_Cter_Amidation | 158 | 161 | PF01082 | 0.610 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.408 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.438 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.349 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.494 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.344 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.751 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.676 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.682 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.678 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.700 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.429 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.406 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.474 |
MOD_NEK2_1 | 294 | 299 | PF00069 | 0.411 |
MOD_NEK2_1 | 322 | 327 | PF00069 | 0.335 |
MOD_PIKK_1 | 217 | 223 | PF00454 | 0.492 |
MOD_PIKK_1 | 232 | 238 | PF00454 | 0.426 |
MOD_PIKK_1 | 50 | 56 | PF00454 | 0.695 |
MOD_PKA_1 | 200 | 206 | PF00069 | 0.405 |
MOD_PKA_2 | 200 | 206 | PF00069 | 0.405 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.746 |
MOD_Plk_1 | 39 | 45 | PF00069 | 0.757 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.703 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.389 |
MOD_Plk_4 | 189 | 195 | PF00069 | 0.465 |
MOD_Plk_4 | 208 | 214 | PF00069 | 0.353 |
MOD_Plk_4 | 220 | 226 | PF00069 | 0.283 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.411 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.703 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.448 |
MOD_ProDKin_1 | 229 | 235 | PF00069 | 0.389 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.762 |
TRG_DiLeu_BaLyEn_6 | 255 | 260 | PF01217 | 0.366 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.485 |
TRG_ER_diArg_1 | 113 | 115 | PF00400 | 0.539 |
TRG_ER_diArg_1 | 160 | 162 | PF00400 | 0.386 |
TRG_ER_diArg_1 | 200 | 202 | PF00400 | 0.581 |
TRG_ER_diArg_1 | 83 | 86 | PF00400 | 0.724 |
TRG_Pf-PMV_PEXEL_1 | 68 | 72 | PF00026 | 0.541 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P732 | Leptomonas seymouri | 56% | 99% |
A0A1X0NVF3 | Trypanosomatidae | 31% | 100% |
A0A3Q8IAV0 | Leishmania donovani | 84% | 100% |
A0A3R7KTP8 | Trypanosoma rangeli | 34% | 100% |
A4I3B5 | Leishmania infantum | 84% | 100% |
D0A7T4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9AZJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4Q8N9 | Leishmania major | 82% | 100% |
V5DAH6 | Trypanosoma cruzi | 36% | 100% |